Viewing Study NCT06248541



Ignite Creation Date: 2024-05-06 @ 8:04 PM
Last Modification Date: 2024-10-26 @ 3:20 PM
Study NCT ID: NCT06248541
Status: RECRUITING
Last Update Posted: 2024-02-08
First Post: 2024-01-25

Brief Title: The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome
Sponsor: Medical University of Graz
Organization: Medical University of Graz

Study Overview

Official Title: The Effect of Low-Level Laser Therapy in Carpal Tunnel Syndrome A Randomized Single-Blinded Placebo-Controlled Trial
Status: RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: KaLi-CTS
Brief Summary: Carpal tunnel syndrome CTS is a chronic compression of the median nerve which can lead to symptoms such as nocturnal pain and paresthesia in the area innervated by the median nerve The affected patients also describe discomfort and hypoesthesia in the nerve supply area Due to the COVID Coronavirus disease pandemic CTS operations have been postponed and delayed A promising and safe alternative for improving CTS-related symptoms appears to be non-invasive non-thermal low-level-laser therapy As a possible conservative alternative method low-level-laser therapy has the potential to enable patients with CTS to improve their disease-related symptoms or at least to alleviate the symptoms until the indicated CTS operation carpal tunnel release

The aim of this randomized single-blind placebo-controlled clinical trial is to investigate the influence of 3 weeks of low-level-laser therapy on the symptoms typical of CTS in patients with surgery-indicated carpal tunnel syndrome and its influence on quality of life
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None